TipRanks
Go Ultimate55% OFF

Stacy Lindborg Insider Profile

4 Followers

Stacy Lindborg, President & CEO, Director at Imunon, holds 119.56K shares in Imunon (Ticker: IMNN), holds 48.23K shares in Brainstorm Cell Therapeutics (Ticker: BCLI).

Stacy Lindborg's Trading History

IMNN
Imunon
Oct 27, 2026President & CEO, DirectorUninformative Buy3.20K$108.80K
BCLI
Brainstorm Cell Therapeutics
Jan 03, 2025DirectorUninformative Buy―$41.48K

You May Also Like

Stacy Lindborg insider profile FAQ

What is the percentage of profitable transactions made by Stacy Lindborg?
The percentage of profitable transactions made by Stacy Lindborg is 0%.
What is the average return per transaction made by Stacy Lindborg?
The average return per transaction made by Stacy Lindborg is -69.70%.
What stocks does Stacy Lindborg hold?
Stacy Lindborg holds: IMNN, BCLI stocks.
What was Stacy Lindborg’s latest transaction?
Stacy Lindborg’s latest transaction was an Uninformative Buy of $3.20K.
What was Stacy Lindborg's most profitable transaction?
Stacy Lindborg’s most profitable transaction was an Informative Buy of IMNN stock on August 16, 2024. The return on the trade was -56.90%.
What is Stacy Lindborg's role in Imunon?
Stacy Lindborg's role in Imunon is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.